Skip to content
Home
About Us
Science
Investors
News
Menu
Home
About Us
Science
Investors
News
Contact Us
Home
About Us
Science
Investors
News
Menu
Home
About Us
Science
Investors
News
Contact Us
NEWS
Company news and the latest scientific findings
BC
,
VANCOUVER
|
Dec 2023
ME THERAPEUTICS HOLDINGS INC. Provides An Overview And Update On Current Research And Development Programs
ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology,
Read More
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Receives Funding Support For Preclinical Testing Of Prodrug Candidates
ME Therapeutics Holdings Inc. (CSE: METX) (the “Company” or “MET”), a preclinical stage biotechnology company working on novel cancer fighting drugs
Read More
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange
ME Therapeutics Holdings Inc. (CSE: METX) (the “Company” or “MET”), a preclinical stage biotechnology company working on novel cancer fighting drugs
Read More
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications
ME Therapeutics Inc., a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased
Read More
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate
ME Therapeutics Inc., a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased
Read More
Check out our profile on SEDAR+
Click here
BC
,
VANCOUVER
|
Dec 2023
ME THERAPEUTICS HOLDINGS INC. Provides An Overview And Update On Current Research And Development Programs
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Receives Funding Support For Preclinical Testing Of Prodrug Candidates
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate
Search
Search
Keep up to date by subscribing to our mailing list
First Name
firstname
Email
JOIN